GenesisCare Shareholders Vote Unanimously to Partner with KKR

GenesisCare Shareholders Vote Unanimously to Partner with KKR

GenesisCare AustraliaMr. Dan Collins, +61 2 8236 3300

GenesisCare shareholders have voted unanimously in favour of affiliates of Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, "KKR") entering into an agreement whereby KKR will own a 49.6 per cent of GenesisCare.

GenesisCare operates an Australia-wide network of comprehensive cancer and cardiovascular care centres. The company is a leader in cancer and cardiovascular service provision and is committed to improving clinical outcomes and access for patients.

Comprising a team of doctors, healthcare specialists and management professionals, GenesisCare embraces a collegiate and innovative spirit that encourages advancements in patient care. The organization has more than 1,000 employees that have helped provide more than 350,000 patient treatments across Australia in the past 12 months.

"KKR acknowledges the unanimous support of the GenesisCare shareholders in voting to approve the agreement, and looks forward to partnering with GenesisCare on their vital mission" said Mr. Justin Reizes, Member of KKR and Head of KKR Australia.

Mr. Dan Collins, Managing Director of GenesisCare, said, "KKR has a long history of investing in health care. Since 1995, the firm has invested more than $9 billion of equity capital in health care companies. They will bring proven global resources and the deep healthcare expertise needed to meet the challenges confronting Australia's healthcare system."

"KKR's support, and the overwhelming support of our shareholders who are also doctors and staff, is a terrific endorsement of the GenesisCare vision and strategy. We can continue to innovate and improve how care is delivered," Mr. Collins added.

GenesisCare provides high quality specialist care to patients with cancer and cardiovascular disease, the two largest disease burdens in Australia. More than 70 clinics and facilities are located across metropolitan and regional Australia.

The GenesisCare medical team comprises some of Australia's most experienced specialists with many dedicating time as consultants in public hospitals or participating in research and teaching. GenesisCare is adopting internationally proven medical technologies integrated with electronic healthcare records to improve patient clinical outcomes and their service experience.

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.